| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $458.5M | +2.7% |
| Cost of Revenue | $311.5M | +2.6% |
| Gross Profit | $147.0M | +2.8% |
| R&D Expense | $47.9M | -3.6% |
| SG&A Expense | $47.9M | -4.4% |
| Operating Income | $7.8M | +1455.4% |
| Interest Expense | $13.0M | +11.4% |
| Pre-tax Income | $1.1M | +109.6% |
| Income Tax | $2.7M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.4M | -16.3% |
| Accounts Receivable | $83.2M | -9.6% |
| Inventory | $141.0M | +1.9% |
| Current Assets | $317.5M | -1.8% |
| Total Assets | $470.2M | +0.3% |
| Current Liabilities | $192.6M | -1.4% |
| Long-term Debt | $136.5M | -20.7% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.9M | +124.0% |
| Capital Expenditures | $4.3M | +18.6% |
| Investing Cash Flow | -$8.5M | -136.7% |
| Financing Cash Flow | -$4.3M | -7.6% |
| Free Cash Flow | -$1.4M | +90.9% |
| -26.8% |
| Net Income | -$1.6M | +89.8% |
| EPS (Basic) | -$0.02 | +87.5% |
| EPS (Diluted) | -$0.02 | +87.5% |
| Total Liabilities |
| $389.1M |
| -8.1% |
| Stockholders' Equity | $81.2M | +80.0% |